Angiotensinogen Met235Thr polymorphism, angiotensin-converting enzyme inhibitor therapy, and the risk of nonfatal stroke or myocardial infarction in hypertensive patients
Titel:
Angiotensinogen Met235Thr polymorphism, angiotensin-converting enzyme inhibitor therapy, and the risk of nonfatal stroke or myocardial infarction in hypertensive patients
Auteur:
Bis, Joshua C. Smith, Nicholas L. Psaty, Bruce M. Heckbert, Susan R. Edwards, Karen L. Lemaitre, Rozenn N. Lumley, Thomas Rosendaal, Frits R.